Host defence (cationic) peptides. What is their future clinical potential?

Drugs

Volumn 57, Issue 4, 1999, Pages 469-473

  Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CATIONIC PEPTIDE; ENDOTOXIN; GRAMICIDIN S; IB 367; NEOMYCIN; NISIN; PEXIGANAN ACETATE; RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; CLINICAL TRIAL; DIABETIC FOOT; EDITORIAL; HOST RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCEMIA; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; CATIONS; CLINICAL TRIALS; HUMANS; PROTEINS;

EID: 0032916291     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199957040-00002     Document Type: Editorial

References (21)

1. 1. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13: 61-92
2. 2. Ganz T, Lehrer RI. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997; 4: 53-8
3. 3. Hancock REW, Falla T, Brown MM. Cationic bactericidal peptides. Adv Microb Physiol 1995; 37: 135-75
4. 4. Hancock REW, Lehrer RI. Cationic peptides: a new source of antibiotics. Trends Biotech 1998; 16: 82-8
5. 5. Kadalayil L, Petersen UM, Engstrom Y. Adjacent GATA and Kappa β-like motifs regulate the expression of a Drosophila immune gene. Nucl Acids Res 1997; 25: 1233-9
6. 6. Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418-22
7. 7. Steinberg DA, Hurst MA, Fujii CA, et al. Protegrin-I: a broad spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 1997; 41: 1738-42
8. 8. Kondejewski LH, Farmer SW, Wishart DS, et al. Gramicidin S is active against both gram-positive and gram-negative bacteria. Int J Peptein Prot Res 1996; 47: 460-6
9. 9. Gough M, Hancock REW, Kelly NM. Anti-endotoxic potential of cationic peptide antimicrobials. Infect Immun 1996; 64: 4922-7
10. 10. Hancock REW. Therapeutic potential of cationic peptides. Expert Opin Invest Dis 1998; 7: 167-74
11. 11. Darveau RP, Cunningham MD, Seaford CL, et al. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 1991; 35: 1153-9
12. 12. Rogy MA, Oldenburg HSA, Calvano SE, et al. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994; 14: 120-33
13. 13. Appenzeller L, Lim E, Wong P, et al. In vivo fungicidal activity of optimized domain III peptides derived from bactericidal/ permeability-increasing protein BPI [abstract F187]. 36th International Conference on Antimicrobial Agents and Chemotherapy: 1996 Sep 17-20; New Orleans, 132
14. 14. Nakashima H, Masuda M, Murakami T, et al. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5, 12,Lys-7] Polyphemusin II): a possible inhibitor of virus-cell fusion. Antimicrob Agents Chemother 1992; 36: 1249-55
15. 15. Rodriguez MC, Zamudio F, Torres JA, et al. Effect of a cecropin-like synthetic peptide (Shiva -3) on the sporogenic development of Plasmodium berghei. Exp Parasitol 1995; 80: 596-604
16. 16. Sawyer JG, Martin NL, Hancock REW. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun 1988; 56: 693-8
17. 17. Moore AJ, Devine DA, Bibby MC. Preliminary experimental anti-cancer activity of cecropin B. Peptide Res 1994; 7: 265-9
18. 18. D'Cruz OJ, Periera A, Haas GG. Sperm immobilizing activity of a synthetic bioactive peptide 20-44 of 37-kDa cationic antimicrobial protein (CAP37) of human neutrophils. J Androl 1995; 16: 432-40
19. 19. Jensen T, Pedersen SS, Garne S, et al. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987; 19: 831-8
20. 20. Ahmad I, Perkins WR, Lupan DM, et al. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim Biophys Acta 1995; 1237: 109-14
21. 21. Piers KL, Brown MH, Hancock REW. Recombinanl DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 1993; 134: 7-13